Discontinuation of first-line chemotherapy (CT) after 6 weeks of CT in patients (pts) with metastatic squamous-cell esophageal cancer (MSEC): A randomized phase II trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreDiscontinuation of first-line chemotherapy (CT) after 6 weeks of CT in patients (pts) with metastatic squamous-cell esophageal cancer (MSEC): A randomized phase II trial
Type de publicationJournal Article
Year of Publication2016
AuteursAdenis A, Bennouna J, Etienne P-L, Bogart E, Francois E, Galais M-P, Ben Abdelghani M, Kotecki N, Michel P, Metges J-P, Dahan L, Piessen G, Conroy T, Ghiringhelli F, Bedenne L, Hajbi FEl, Samalin E, Delaine SClisant, Penel N, Mariette C
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.4002